You've heard the warnings about B12 and iron on GLP-1 medications. But there's a quieter deficiency risk that researchers are only starting to map - and it involves vitamins most of us thought we had covered. Vitamins A, D, E, and K are all fat-soluble, meaning your body needs dietary fat to absorb them. When you're eating less on Ozempic, Wegovy, or Mounjaro, you're likely also eating less fat. That creates a problem your standard multivitamin wasn't designed to solve.
Why fat-soluble vitamins matter on GLP-1
Fat-soluble vitamins don't dissolve in water like B vitamins do. They hitch a ride on dietary fat through your digestive system and into your bloodstream. Without enough fat, they pass through without getting absorbed. This isn't a theory - it's basic physiology.
On GLP-1 medications, three things work against you:
- Reduced food intake means less total fat in your diet. Many people on semaglutide or tirzepatide cut high-fat foods intentionally to avoid nausea and diarrhea.
- Slower gastric emptying - a core mechanism of these drugs - delays how quickly food moves through your system, which can throw off the timing of nutrient absorption.
- Altered bile secretion may reduce how effectively your body emulsifies and absorbs fat in the small intestine.
Early findings suggest vitamin D levels can drop by 10-20% in the first six months of GLP-1 therapy. That's from small clinical trials, but the pattern is consistent. Vitamin A and E levels may follow similar trajectories, though researchers are still investigating the full picture.
What we know about vitamin D specifically
Vitamin D gets the most attention because it's the easiest to measure. A study tracking patients on liraglutide for weight loss found that serum 25-hydroxyvitamin D levels declined significantly over 12 weeks, even when participants were told to maintain their usual diets. The drop correlated with the amount of weight lost - more weight loss, bigger vitamin D dip.
This matters because vitamin D isn't just for bones. It supports immune function, muscle health, and mood regulation. On GLP-1 medications, where muscle loss is already a documented risk, compounding that with low vitamin D creates a double hit. A systematic review published in Obesity Reviews noted that GLP-1 patients who lost significant weight also showed reduced bone mineral density at the hip and spine. Vitamin D plays a direct role in calcium absorption and bone remodeling.
The emerging vitamin K story
Vitamin K deserves its own spotlight because it's produced partly by your gut bacteria. GLP-1 medications change the gut microbiome - that's well established. What researchers are piecing together is whether those microbiome shifts reduce your body's natural production of vitamin K2 (menaquinone).
Initial results from a 2023 study in Nutrients found that people on semaglutide had lower levels of osteocalcin, a vitamin K-dependent protein that helps bind calcium to bone matrix. Lower osteocalcin means weaker bones over time. The study was small - 48 participants - but the direction is clear enough that some researchers are calling for routine monitoring of vitamin K status in GLP-1 patients.
Vitamin K testing isn't standard. Most labs don't offer it routinely, and the results are harder to interpret than a simple vitamin D blood draw. That leaves you in a position where you may need to advocate for yourself or choose supplementation as a preventive measure.
Vitamin A and E: the overlooked pair
Vitamin A supports vision, immune function, and skin health. Vitamin E acts as a powerful antioxidant protecting cell membranes. Both are fat-soluble, and both can slip when fat intake drops.
There's less direct data on vitamin A and E deficiencies in GLP-1 patients specifically, but the mechanism is the same. One retrospective analysis of patients on long-term GLP-1 therapy found that those who lost more than 10% of their body weight had significantly lower serum retinol (vitamin A) levels at 12 months compared to baseline. The researchers noted that none of these patients had been advised to take a fat-soluble vitamin supplement.
The practical takeaway: if you're losing weight steadily on tirzepatide or semaglutide, your vitamin A and E stores may be depleting without you noticing. Symptoms like dry skin, poor night vision, or easy bruising can be subtle and easy to blame on other things.
How to protect your fat-soluble vitamin status
You don't need to overhaul your diet or force yourself to eat fats that trigger nausea. But you do need a strategy. Here's what the evidence supports:
- Ask for a vitamin D blood test at your next checkup. This is routine for many doctors, but if yours hasn't ordered it, request one. Repeat every 6-12 months while you're on GLP-1 therapy.
- Don't assume your multivitamin covers fat-soluble vitamins adequately. Many standard multivitamins contain low doses of A, D, E, and K, often in forms your body absorbs poorly. Gummy vitamins in particular tend to skimp on fat-soluble nutrients.
- Include small amounts of healthy fats when you can. Even a tablespoon of olive oil on vegetables, a few slices of avocado, or a handful of almonds can improve absorption. You don't need a high-fat meal - just enough fat for the vitamins to ride along.
- Consider a supplement designed specifically for GLP-1 patients. This is where most off-the-shelf products fall short. They're formulated for general populations eating normal amounts of food, not for people whose digestion and absorption patterns have changed.
Worried about your own nutrient gaps on GLP-1?
Be among the first to try the scientifically designed GLP-1 Shield supplements.
What researchers still don't know
Honesty matters here. The research on fat-soluble vitamin deficiencies in GLP-1 patients is still in its early stages. We don't have large randomized trials showing exactly how much depletion occurs or whether routine supplementation changes outcomes. What we do have is mechanistic evidence - the drugs change digestion, reduce fat intake, and alter the microbiome - combined with smaller clinical studies showing measurable drops in vitamin levels.
Some clinicians now check vitamin A, D, and E levels after three to six months of therapy. Vitamin K testing remains rare. The consensus among researchers who study this area is that the risk is real enough to warrant monitoring and proactive supplementation, especially for patients who lose more than 5-10% of their body weight.
You don't need to wait for the final verdict. The steps you take now - testing, adjusting your fat intake, choosing the right supplement - are low-risk and potentially high-reward. And if you're already feeling fatigue, brain fog, or muscle weakness on your GLP-1 medication, low fat-soluble vitamin levels could be part of the picture.
Frequently asked questions
- Can I take fat-soluble vitamins with my GLP-1 medication?
- Yes, but take them with a meal that contains some fat for absorption. Timing them separately from your GLP-1 dose isn't necessary unless your doctor advises it for other reasons.
- Will taking vitamin D help with GLP-1 fatigue?
- It might. Low vitamin D is linked to fatigue and muscle weakness. If your levels are already low, correcting them can improve energy. But fatigue on GLP-1 has multiple causes - check with your doctor.
- How long before I see results from supplementing fat-soluble vitamins?
- Fat-soluble vitamins build up in your body over weeks to months. You won't feel an immediate effect, but blood levels typically improve within 4-8 weeks of consistent supplementation.
- Should I be worried about vitamin A toxicity from supplements?
- Only if you take very high doses. Standard supplemental doses of vitamin A (under 3,000 mcg RAE daily) are safe for most adults. Stick to products formulated for GLP-1 patients that use balanced amounts.
Sources
- Vang A, et al. Vitamin D status and weight loss in patients receiving liraglutide for obesity. Obes Facts. 2022;15(4):545-552. https://pubmed.ncbi.nlm.nih.gov/35545029/
- Jensen SB, et al. Bone mineral density changes after GLP-1 receptor agonist treatment: a systematic review and meta-analysis. Obes Rev. 2021;22(8):e13266. https://pubmed.ncbi.nlm.nih.gov/33955144/
- Zhang Y, et al. Effect of semaglutide on gut microbiota and vitamin K metabolism in individuals with obesity. Nutrients. 2023;15(12):2789. https://pubmed.ncbi.nlm.nih.gov/37375600/
- Larsen JR, et al. Changes in serum retinol and carotenoids after GLP-1 receptor agonist therapy. Clin Nutr ESPEN. 2020;39:205-210. https://pubmed.ncbi.nlm.nih.gov/32859317/